Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here
Updated : September 17, 2019 06:45 AM IST
Chimeric Antigen Receptor (CAR) T-cell therapy is currently not available in India.
In the US, two drugs approved for this therapy are sold for nearly Rs 3 crore per person.
Working on reducing the price of this drug in India by tenfold.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more